Perspective
Nature Reviews Drug Discovery 5, 641-647 (August 2006) | doi:10.1038/nrd2035
Essay: Applying the concepts of financial options to stimulate vaccine development
David Brogan1 & Elias Mossialos1 About the authors
Abstract
Stimulating research and development for neglected diseases (such as tuberculosis, malaria and AIDS) has proven difficult. We offer an alternative approach to stimulating research into neglected diseases based on the concept of a financial call option. Our Call Options for Vaccines (COV) model allows the purchaser to make payments during the early stages of development in exchange for reduced future prices. We conclude with a discussion of possible risks and benefits.
Author affiliations
-
David Brogan is a Research Associate in Health Economics, and Elias Mossialos is Professor of Health Policy, at LSE Health, London School of Economics and Political Science, Houghton Street, London WC2A 2AE, United Kingdom.
Email: d.m.brogan@lse.ac.uk
Email: e.a.mossialos@lse.ac.uk
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Engineering Oncolytic Measles Virus to Circumvent the Intracellular Innate Immune ResponseMolecular Therapy Original Article
Honorable disposals as planned exit routes?Nature Biotechnology Strategic Planning (01 May 1999)
Biotech's Platform Technologies Lure Big PharmaBio/Technology Article (01 Sep 1995)
Insurability of Climate RisksThe Geneva Papers on Risk and Insurance Issues and Practice Original Article
See all 8 matches for Research